INTRODUCTION
Endogenous opioids and their receptors play a key role in brain function and have been implicated in several disease-related processes. Administration of exogenous opiates continues to be one of the best tools for the relief of pain; however, repeated use of these drugs can lead to tolerance, physical dependence, and psychological addiction (Simon, 1991) . Opioid receptors have been classified into three major types, µ, d, and k, based on their pharmacological profiles. In addition, there are well-described anatomical, physiological, and behavioral differences among these three major classes (Simon, 1991; Wood, 1982; Mansour & Watson, 1993; Lord et al., 1977) . Each of them exhibits high binding affinity to a specific subset of the endogenous opioids, allowing each type to mediate different physiological functions. The µ receptor is of particular interest since it is selective for drugs such as morphine and heroin and mediates the classic opiate functions such as analgesia, opiate reward, and opiate addiction. The three major types of opioid receptors have recently been cloned, including d (Kieffer et al., 1992; Evans et al., 1992 ), µ (Chen et al., 1993 Thompson et al., 1993; Wang et al., 1993; Yasuda et al., 1993), and k (Meng et al., 1993; Minami et al., 1993; Fukuda et al., 1993) , and have been shown to belong to the large family of G-proteincoupled receptors which has a characteristic structure with seven transmembrane helices, three extracellular and three intracellular loops, an extracellular Nterminal domain, and an intracellular C-terminal domain.
One of the interesting aspects of the opioid family is the availability of a variety of classes of ligands, including endogenous peptide ligands, such as mammalian and amphibian endorphins, and synthetic ligands, both alkaloids and peptides, and both agonists and antagonists. This makes it possible to ask whether peptidic and nonpeptidic ligands interact with the receptors at the same or at different sites, and whether
